Why Most Minimum Annual Royalty Clauses Fail to Protect Anyone's Interests
Minimum annual royalty clauses are meant to protect universities from dormant licenses, but most are drafted in ways that undermine both parties from the start.
A. Kovacs Topic
licensing
16 posts tagged licensing from Commercializing Science.
A. Kovacs More on licensing
Why Most University Licensing Audit Rights Go Unexercised Until It's Too Late
Audit rights in license agreements are among the most valuable and most neglected tools in technology transfer. Here's why that keeps costing universities money.
A. KovacsWhy Most Universities Negotiate License Royalty Stacking Clauses Into Oblivion
Royalty stacking provisions look like licensee protection but often destroy deal economics. Here's what universities get wrong and how to fix it.
A. KovacsWhy Most Bayh-Dole Compliance Programs Miss the Point Entirely
Bayh-Dole compliance at most universities is a defensive legal exercise. Here's why that posture quietly destroys commercialization potential.
A. KovacsWhy Most Patent Claim Drafting Strategies Leave Commercialization Value on the Table
Most patent claims are drafted to survive examination, not to support licensing deals. Here's what gets lost when prosecution strategy ignores commercial reality.
A. KovacsWhy Most Reach-Through Royalty Claims Poison University-Industry Deals Before They Close
Reach-through royalty provisions look like smart IP protection but routinely kill university-industry deals. Here's what to do instead.
A. KovacsWhy Most Invention Valuation Methods Produce Numbers Nobody Actually Believes
Most invention valuation methods in tech transfer generate figures that satisfy spreadsheets but fail negotiations. Here's what actually works.
A. KovacsWhy Most Milestone Structures in License Agreements Reward the Wrong Behavior
Most license milestone structures protect universities from inaction but accidentally punish real development progress. Here's what to do instead.
A. KovacsWhy Most Sublicensing Provisions Quietly Transfer Your Leverage to Someone Else
Sublicensing provisions in university license agreements often hand control to licensees by default. Here's what to negotiate before it's too late.
A. KovacsWhy Most Patent Prosecution Strategies Ignore the Commercialization Window Entirely
Most university patent prosecution focuses on legal coverage, not commercial timing. Here's why that mismatch quietly kills licensing deals before they start.
A. KovacsWhy Most Royalty Rate Negotiations Start From the Wrong Number
Most tech transfer royalty negotiations anchor on industry averages and gut feel. Here's why that produces bad deals and what to use instead.
A. KovacsWhy Most Material Transfer Agreements Quietly Kill Downstream Commercialization
MTAs look like administrative paperwork, but buried clauses routinely strip universities and startups of the IP rights they need to commercialize research.
A. KovacsWhy Most Field-of-Use Restrictions in License Agreements Create More Problems Than They Solve
Field-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsWhy Exclusive Licenses Destroy More Value Than They Create
Exclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsWhy Option Agreements Are the Most Misused Tool in Technology Transfer
Option agreements should de-risk early licensing deals, but most TTOs use them wrong. Here's what's broken and how to fix it.
A. KovacsWhy Most Licensing Term Sheets Die in Negotiation (And How to Rescue Them)
Most university licensing deals collapse not because of bad science or bad intent, but because of preventable negotiation failures. Here's what actually goes wrong.
A. Kovacs Browse more topics